Transgene Announces Publication in “The Lancet Oncology” of Phase 2b TIME Trial Results with TG4010 Immunotherapy in Non-Small Cell Lung Cancer
20151223_TIME Ph2b Lancet Oncology 2015_PR EN
20151223_TIME Ph2b Lancet Oncology 2015_PR EN
Elisabeth Quoix, et al. The Lancet Oncology, December 2015, 17: [...]
John Nemunaitis, et al. SITC 2015, November 2015 – Abstract [...]
Elisabeth Quoix, et al. 16th World Conference on Lung Cancer. [...]
19 August 2015_PR_IASLC curtain raiser_ENG
20150601 PR TG4010 TIME results_ASCO 2015_FINAL
Elisabeth Quoix, et al. ASCO Annual Meeting 2015 - May [...]
Poster TG4010-AACR 2015-KR Karola Rittner, et al. AACR Annual Meeting, [...]